GE HealthCare (GEHC) has named Roland Rott as the company's president and CEO of Imaging and Phil Rackliffe as president and CEO of Ultrasound and Image Guided Therapies. These changes will be effective July 1.
Rott joined GE HealthCare in 2011 and has held multiple leadership roles within the ultrasound segment, becoming president and CEO in 2021.
Rackliffe joined GE HealthCare in 2022 to lead Image Guided Therapies. Since joining, he has led R&D expansion related to new product introductions including Allia Pulse, 3DStent, EmboAssist AI and OmnifyXR.
IGT, a $1.6 billion subsegment of Imaging, will be combined with the Ultrasound segment in the third quarter of 2024, to form a global business, the company said. GE HealthCare said it is aligning Image Guided Therapies with Ultrasound to better match its clinical usage and realize stronger business and customer impact.
GE HealthCare said it expects to provide recast financial results to reflect the movement of Image Guided Therapies from Imaging to the new Ultrasound and Image Guided Therapies segment in its filings with the U.S. Securities and Exchange Commission (SEC) for the third quarter of 2024.
